Stay updated with breaking news from Baxalta takeda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As per DelveInsight, the Thrombocytopenia market size in the 7MM was observed to be USD 4,412 million in 2021, which is expected to grow by 2032. The ....
Market players such as Sanofi, Rigel Pharmaceuticals, Kissei Pharmaceutical, Sobi, Shionogi & Co., Ltd., Amgen, Novartis, Zenyaku Kogyo, UCB Biopharma, Principia Biopharma, Baxalta, Takeda, Argenx, GC Pharma, Omeros Corporation, Biotest, Millennium Pharmaceuticals, Cellphire, Momenta Pharmaceuticals, ILTOO Pharma, Genosco, and several others are involved in developing Thrombocytopenia therapies. Thrombocytopenia market might experience significant growth due to the expected launch of upcoming therapies such as Rozanolixizumab (UCB7665); Rilzabrutinib (PRN-1008); BAX930; Efgartigimod (ARGX-113); Cablivi (caplacizumab); Tavalisse/Tavlesse (Fostamatinib); Doptelet (Avatrombopag); Nplate (Romiplostim); and Mulpleta (lusutrombopag), and others. For additional information on Market Impact by Therapies, visit: Thrombocytopenia is a condition in which the blood has a lower than a normal number of platelets. The condition can be inherited or acquired. Thrombocytop ....